DZIF-Ab-Core is a central platform for the rapid and comprehensive evaluation of new antibody candidates for the prevention and treatment of infectious diseases. DZIF-Ab-Core provides state-of-the-art technological support for researchers within the DZIF network to effectively address global challenges such as antimicrobial resistance and emerging viruses.
Through a secure online interface, members can submit antibody sequences and select from a range of specialized tools and analyses - flexibly and on a need-based basis. Preclinical analyses and antibody production are carried out across sites by experienced partners within DZIF.
Services offered by the DZIF-Ab-Core platform: Online interface for structured submission and project planning; Evaluation of antibody sequences (e.g., liability assessment); In vivo analyses for PK determination in relevant models; Structural analyses as well as poly- and autoimmunity reactivity testing; Assessment of manufacturability and mid-scale production; Fc engineering and functional characterization of Fc-mediated effectors.
To offer you an optimal experience, we use technologies such as cookies. This site does not use cookies to store personal data, but only technically necessary cookies such as the session cookie. To the privacy policy